<?xml version="1.0" encoding="UTF-8"?>
<fig id="ijms-21-03474-f003" orientation="portrait" position="float">
 <label>Figure 3</label>
 <caption>
  <p>Hypothesized mechanism of a genetic–environmental interaction between ACE1/ACE2 genes and SARS-CoV-2 infection. (
   <bold>a</bold>) Normal-health condition with a balanced RAS, normal Ang-II levels (Ang-II ↓↑), in the absence of virus infection. (
   <bold>b</bold>) Over-expression of ACE1 receptor as in the presence of the 
   <italic>ACE1</italic> DD-genotype (i.e., rs4646994, rs1799752, rs4340, rs13447447) in combination with ACE2 downregulation due to SARS-CoV-2 infection and/or in the presence of the 
   <italic>ACE2</italic> 8790 G-allele (i.e., rs2285666), resulting in ACE1/ACE2 unbalancing, RAS over-activation (Ang-II ↑) and lung shut-down. (
   <bold>c</bold>) Under-expression of ACE1 receptor as in the presence of the 
   <italic>ACE1</italic> II-genotype (i.e., rs4646994, rs1799752, rs4340, rs13447447) in combination with ACE2 downregulation due to SARS-CoV-2 infection counteracted by the 
   <italic>ACE2</italic> 8790 A-allele (i.e., rs2285666), resulting in ACE1/ACE2 re-balancing, no RAS over-activation, re-balanced Ang-II levels (Ang-II ↓↑), and no lung shut-down. ADAM17: metallopeptidase domain 17; ARBs: angiotensin receptor blockers; MRAs: mineralocorticoid receptor antagonists.
  </p>
 </caption>
 <graphic xlink:href="ijms-21-03474-g003a" xmlns:xlink="http://www.w3.org/1999/xlink"/>
 <graphic xlink:href="ijms-21-03474-g003b" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
